Altach Biomedical Engages Investors and Key Industry Leaders at LSI USA 2025

April 2025 – Dana Point, CA

Following a successful appearance at AAOS 2025, Altach Biomedical continued to build momentum at LSI USA 2025, a premier MedTech conference designed to connect CEOs with investors and strategic partners. Held in Dana Point, California, the conference’s highly curated networking environment ensured a strong ratio of investors to executives, fostering meaningful and sustained engagement.

Altach’s CEO, Tomir Kosowski, delivered a formal company presentation, showcasing the company’s innovative cartilage repair solutions. He was also selected to participate in an influential panel discussion titled “Beyond Robotics: What’s Shaping the Future in Orthopaedics”. Moderated by NLC’s Kim High, the panel featured prominent industry leaders, including:

• Chris Campbell, Director of Platform Strategy at Johnson & Johnson
• Adam Wollowick, Senior Director of Business Development at Stryker
• Brian Hess, CEO of RevBio

This engaging session offered valuable visibility for Altach among senior decision-makers from leading orthopaedic companies. The discussions sparked significant interest, and many strategics followed up with Altach for deeper, more focused conversations.

Altach Biomedical’s participation in LSI USA 2025 reinforces our commitment to fostering strong relationships within the MedTech industry and advancing the future of cartilage repair technology.